Literature DB >> 25040045

HBV/HDV co-infection in the Western Brazilian Amazonia: an intriguing mutation among HDV genotype 3 carriers.

A Kay1, E Melo da Silva, H Pedreira, S Negreiros, C Lobato, W Braga, R Muwonge, P Dény, M Reis, F Zoulim, C Trepo, A D'Oliveira, J M Salcedo, M I Schinoni, R Parana.   

Abstract

HDV infection still remains a serious public health problem in Amazonia. There are few data regarding the biomolecular aspects of HBV/HDV co-infection in this region. We studied 92 patients HBsAg(+) /anti-HDV IgG(+) followed at the Hepatitis Referral Centers of Porto Velho (RO), Rio Branco and Cruzeiro do Sul (AC), Brazil, from March 2006 to March 2007 for whom the HDV and/or the HBV genotype could be determined. The HDV genotype could be determined in 90 patients, while the HBV genotypes could be positively determined in 74. HBV subgenotype F2 is the most prevalent (40.2%), followed by the subgenotypes A1 (15.2%) and D3 (8.7%), while 16.4% were other subgenotypes or genotypes, 4.3% were discordant and 15.2% were unamplifiable. Surprisingly, HDV genotype 3 (HDV-3) was found in all of the HBV/HDV-infected patients that could be genotyped for HDV, confirming that HDV-3 can associate with non-F HBV genotypes. However, a HDV-3 mutant was found in 29.3% of patients and was more frequently associated with non-F HBV genotypes (P < 0.001) than were nonmutant strains, suggesting that the mutation may facilitate association of HDV-3 with non-F HBV genotypes.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  HBV/HDV co-infection; HBV/HDV genotypes; HDV genotype 3; mutant HDV genotype 3

Mesh:

Substances:

Year:  2014        PMID: 25040045     DOI: 10.1111/jvh.12267

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  3 in total

1.  Prevalence and predictors for compensated Advanced Chronic Liver Disease (c-ACLD) in patients with chronic Hepatitis Delta Virus (HDV) infection.

Authors:  Ingrid Couto; Marilu Victoria; Valdiléa G Veloso; Lorena Rodrigues; Beatriz Grinsztejn; Marcus Lacerda; Flamir Victoria; Hugo Perazzo
Journal:  PLoS One       Date:  2017-03-22       Impact factor: 3.240

2.  Hepatitis B Virus Stimulated Fibronectin Facilitates Viral Maintenance and Replication through Two Distinct Mechanisms.

Authors:  Sheng Ren; Jun Wang; Tie-Long Chen; Hao-Yu Li; Yu-Shun Wan; Nan-Fang Peng; Xi-En Gui; Ying Zhu
Journal:  PLoS One       Date:  2016-03-29       Impact factor: 3.240

3.  Hepatitis B and hepatitis D virus infections in the Central African Republic, twenty-five years after a fulminant hepatitis outbreak, indicate continuing spread in asymptomatic young adults.

Authors:  Narcisse Patrice Komas; Sumantra Ghosh; Mariama Abdou-Chekaraou; Pierre Pradat; Nasser Al Hawajri; Alexandre Manirakiza; Gina Laure Laghoe; Claudine Bekondi; Ségolène Brichler; Jean-Omer Ouavéné; Abdoulaye Sépou; Brice Martial Yambiyo; Jean Chrysostome Gody; Valentin Fikouma; Athénais Gerber; Natali Abeywickrama Samarakoon; Dulce Alfaiate; Caroline Scholtès; Nora Martel; Frédéric Le Gal; Hugo Lo Pinto; Ikram Amri; Olivier Hantz; David Durantel; Jean-Louis Lesbordes; Emmanuel Gordien; Philippe Merle; Tudor Drugan; Christian Trépo; Fabien Zoulim; Jean-Claude Cortay; Alan Campbell Kay; Paul Dény
Journal:  PLoS Negl Trop Dis       Date:  2018-04-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.